Effect of isolated fractions of Harpagophytum procumbens D.C. (devil's claw) on COX-1, COX-2 activity and nitric oxide production on whole-blood assay

Phytotherapy Research

Volumn 24, Issue 9, 2010, Pages 1365-1369

  Anauate, Maria Cecilia ^a   Torres, Luce Maria ^b   De Mello, Suzana Beatriz Veríssimo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b São Paulo Air Force Hospital   (Brazil)

Author keywords

COX 1; COX 2; Harpagophytum procumbens; Nitric oxide

Indexed keywords

CINNAMIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ETORICOXIB; HARPAGOPHYTUM PROCUMBENS EXTRACT; HARPAGOSIDE; INDOMETACIN; IRIDOID; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROSTAGLANDIN E2;

ANIMAL CELL; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ENZYME ACTIVATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; THIN LAYER CHROMATOGRAPHY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD CHEMICAL ANALYSIS; BLOOD COAGULATION; BLOOD PLATELETS; CINNAMATES; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; FEMALE; GLYCOSIDES; HARPAGOPHYTUM; HUMANS; INDOMETHACIN; INFLAMMATION MEDIATORS; IRIDOIDS; LIPOPOLYSACCHARIDES; NITRIC OXIDE; PLANT EXTRACTS; PYRANS; PYRIDINES; SULFONES; THROMBOXANE B2;

HARPAGOPHYTUM PROCUMBENS;

EID: 77957252386     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3124     Document Type: Article

References (26)

1. Abdelouahab N, Heard C. 2008. Effect of the major glycosides of Harpagophytum procumbens (devil's claw) on epidermal cyclooxygenase-2 (COX-2) in vitro. J Nat Prod 71: 746-749. (Pubitemid 351841415)
2. Andersen ML, Santos EH, Seabra ML, Silva AA, Tufik S. 2004. Evaluation of acute and chronic treatments with Harpagophytum procumbens on Freund's adjuvant-induced arthritis in rats. J Ethnopharmacol 91: 325-330.
3. Chantre P, Cappelaere A, Leblan D, Guedon D, Vandemander J, Ournie B. 2000. Efficacy and tolerance of Harpagophytum procumbens versus diacerhein in treatment of osteoarthritis. Phytomedicine 7: 177-183. (Pubitemid 30415074)
4. Chrubasik S, Conradt C, Black A. 2003a. The quality of clinical trials with Harpagophutym procumbens. Phytomedicine 10: 613-623.
5. Chrubasik S, Conradt C, Roufogalis BD. 2004. Effectiveness of Harpagophytum extracts and clinical efficacy. Phytother Res 18: 187-189.
6. Chrubasik S, Model A, Black A, Pollak S. 2003b. A randomized double-blind pilot study comparing Dolofetin and Vioxx in the treatment of low back pain. Rheumatology 42: 141-148.
7. Clarkson C, Staerk D, Hansen SH, Smith PJ, Jaroszewski JW. 2006. Identification of major and minor constituents of Harpagophytum procumbens (devil's claw) using HPLCSPE- NMR and HPLC-ESIMS/ APCIMS. J Nat Prod 69: 1280-1288. (Pubitemid 44568234)
8. Ding AH, Nathan CF, Sturhr DJ. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages comparison of activating cytokines and evidence for independent production. J Immunol 141: 2407-2412.
9. Fiebich BL, Heinrich M, Hiller KO, Kammerer N. 2001. Inhibition of TNF-α synthesis in LPS-stimulated primary human monocytes by Harpagophytum extract SteiHap 69. Phytomedicine 8: 28-30. (Pubitemid 32242089)
10. Gilliam MB, Sherman MP, Griscavage JM, Ignarro IJ. 1993. A spectrophotometric assay for nitrate using NADPH oxidation by Aspergillus nitrate reductase. Ann Biochem 212: 359-365.
11. Huang TH, Tran VH, Duke RK et al. 2006. Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-kappa B activation. J Ethnopharmacol 104: 149-155.
12. Jang MH, Lim S, Han SM et al. 2003. Harpagophytum procumbens suppresses lipopolysaccharide-stimulated expressions of cyclooxygenase-2 and inducible nitric oxide synthase in fibroblast cell line L929. J Pharmacol Sci 93: 367-371.
13. Kaszkin M, Beck KF, Koch E et al. 2004. Downregulation of iNOS expression in rat mesangial cells by special extracts of Harpagophytum procumbens derives from harpagoside dependent and independent effects. Phytomedicine 11: 585-595.
14. Lanhers MC, Fleurentin J, Mortier F, Vinche A, Younos C. 1992. Anti-inflammatory and analgesics effects of an aqueous extract of Harpagophytum procumbens. Planta Med 58: 117-123.
15. Lee HS, Kim BS, Kim MK. 2002. Suppression effect of Cinnamomum cassia bark-derived component on nitric oxide synthase. J Agric Food Chem 50: 7700-7703.
16. Loew D, Mollerfeld J, Schrodte A, Puttkammer S, Kaszkin M. 2001. Investigations on the pharmacokinetic properties of Harpagophytum extracts and their effects on eicosanoid biosynthesis in vitro and ex vivo. Clin Pharmacol Ther 69: 356-364. (Pubitemid 32477077)
17. Mello SB, Barros DM, Silva AS, Laurindo IM, Novaes GS. 2000. Methotrexate as a preferential cyclooxygenase 2 inhibitor in whole blood of patients with rheumatoid arthritis. Rheumatology 39: 33-36.
18. Moussard C, Alber D, Toubin MM, Thevenon N, Henry JC. 1992. A drug used in traditional medicine, Harpagophytum procumbens: no evidence for NSAID-like effects on whole blood eicosanoid production in human. Prostaglandins Leuk Essent Fatty Acids 46: 283-286.
19. Ouitas NA, Heard C. 2009. Estimation of the relative antiinflammatory efficacies of six commercial preparations of Harpagophytum procumbens (devil's claw). Phytother Res Jul 16. Epub ahead of print.
20. Patrignani P, Panara MR, Greco A et al. 1994. Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J Pharmacol Exp Ther 271: 1705-1712.
21. Spelman K, Burns J, Nichols D, Winters N, Ottersberg S, Tenborg M. 2006. Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators. Altern Med Rev 11: 128-150.
22. Tacconelli S, Capone ML, Sciulli MG, Ricciotti E, Patrignani P. 2002. The biochemical selectivity of novel COX-2 inhibitors in whole assays of COX-isozyme activity. Curr Med Res Opin 18: 503-511. (Pubitemid 36133053)
23. Wagner H, Bladt S. 1996. Plant Drug Analysis: A Thin Layer Chromatography Atlas, 2nd edn. Springer-Verlag: Berlin Heldelberg.
24. Wallerath T, Li H, Godtel-Ambrust U, Schwarz PM, Forstermann U. 2005. A blend of polyphenolic compounds explains the stimulatory effect of red wine on human endothelial NO synthase. Nitric Oxide 12: 97-104.
25. Warnock M, McBean D, Suter A, Tan J, Whittaker P. 2007. Effectiveness and safety of Devil's Claw tablets in patients with general rheumatic disorders. Phytother Res 21: 1228-1233.
26. Zarate R, Yeoman S, Yeoman MM. 1992. Application of two rapid techniques of column chromatography to separate the pungent principles of ginger, Zingiber officinale Roscoe. J Chromatogr 609: 407-413.